eFFECTOR Therapeutics, Inc. (EFTR) Balance Sheet
EFTR balance sheet, 2023
December 31, 2023 · U.S. dollars$20.5M assets = $26.3M liabilities + −$5.8M equity
Liabilities exceed assets: shareholders’ equity is negative (−$5.8M).
Both columns are drawn to the same scale: what EFTR owns equals what it owes plus shareholders’ equity. Hover a block for its value.
EFTR financial health
Descriptive bands, not a rating. Fiscal 2023.
EFTR balance sheet trends, 2019–2023
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $5.1M2019 | $20.5M2023 | +41.7%/yr | |
| Total liabilities | $18.9M2019 | $26.3M2023 | +8.6%/yr | |
| Shareholders’ equity | −$13.8M2019 | −$5.8M2023 | — | |
| Cash & short-term investments | $3.4M2019 | $18.4M2023 | +52.2%/yr | |
| Total debt | $15.2M2019 | $20.5M2023 | +7.7%/yr | |
| Net cash (debt) | −$11.8M2019 | −$2.2M2023 | +$9.6M | |
| Working capital | −$14.7M2019 | −$6.0M2023 | +$8.7M | |
| Book value per share | $10.702021 | −$2.652023 | — | |
| Current ratio | 0.232019 | 0.772023 | +0.54 | |
| Debt / equity | 13.242020 | 5.212022 | −8.03 | |
| Shares outstanding | 1.6M2021 | 2.2M2023 | +16.3%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
EFTR assets
EFTR liabilities and equity
EFTR debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
EFTR balance sheet
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & short-term investments | $18.4M | $26.3M | $49.7M | $15.2M | $3.4M |
| Cash & equivalents | $14.9M | $8.7M | $49.7M | $15.2M | $3.4M |
| Short-term investments | $3.5M | $17.6M | $0 | — | — |
| Receivables | $52,000 | $27,000 | $100,000 | $0 | $0 |
| Inventory | $0 | −$27,000 | −$100,000 | $0 | $0 |
| Other current assets | $1.4M | $1.7M | $3.2M | $1.4M | $845,000 |
| Total current assets | $19.8M | $28.0M | $52.9M | $16.6M | $4.3M |
| Property, plant & equipment (net) | $193,000 | $352,000 | $257,000 | $126,000 | $823,000 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $513,000 | $711,000 | $903,000 | $0 | $0 |
| Total assets | $20.5M | $29.1M | $54.1M | $16.7M | $5.1M |
| Liabilities | |||||
| Accounts payable | $2.3M | $1.5M | $516,000 | $347,000 | $598,000 |
| Short-term debt | $20.5M | $20.2M | $44,000 | $6.0M | $15.2M |
| Deferred revenue | — | — | — | $2.0M | — |
| Total current liabilities | $25.8M | $25.1M | $4.0M | $8.8M | $18.9M |
| Long-term debt | $0 | $0 | $19.9M | $6.9M | $0 |
| Lease obligations | $60,000 | $120,000 | $170,000 | $108,000 | — |
| Other long-term liabilities | $543,000 | $106,000 | $12.9M | $133.2M | $0 |
| Total liabilities | $26.3M | $25.2M | $36.8M | $148.9M | $18.9M |
| Shareholders' equity | |||||
| Common stock & paid-in capital | — | $4,000 | $4,000 | $454 | $1,000 |
| Retained earnings (deficit) | −$179.4M | −$143.6M | −$120.9M | −$136.7M | −$150.9M |
| Accumulated other comprehensive income | $0 | −$18,000 | $0 | −$133.2M | −$999 |
| Total shareholders' equity | −$5.8M | $3.9M | $17.3M | $979,000 | −$13.8M |
| Key figures | |||||
| Total debt | $20.5M | $20.3M | $20.0M | $13.0M | $15.2M |
| Net cash (debt) | −$2.2M | $6.0M | $29.7M | $2.3M | −$11.8M |
| Working capital | −$6.0M | $2.9M | $48.9M | $7.8M | −$14.7M |
| Tangible book value | −$5.8M | $3.9M | $17.3M | $979,000 | −$13.8M |
| Book value per share | −$2.65 | $2.37 | $10.70 | — | — |
| Shares outstanding | 2.2M | 1.6M | 1.6M | — | — |
| Current ratio | 0.77 | 1.12 | 13.30 | 1.89 | 0.23 |
| Quick ratio | 0.71 | 1.05 | 12.52 | 1.73 | 0.18 |
| Debt / equity | — | 5.21 | 1.16 | 13.24 | — |
| Equity / assets | −28.2% | 13.4% | 32.0% | 5.9% | −271.6% |
| Mar '24 | Dec '23 | Sep '23 | Jun '23 | Mar '23 | Dec '22 | Sep '22 | Jun '22 | Mar '22 | Dec '21 | Sep '21 | Jun '21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $25.4M | $18.4M | $17.8M | $25.0M | $19.0M | $26.3M | $33.0M | $41.0M | $45.7M | $49.7M | $54.8M | $10.9M |
| Cash & equivalents | $15.5M | $14.9M | $5.4M | $14.7M | $10.3M | $8.7M | $11.9M | $16.4M | $17.7M | $49.7M | $54.8M | $10.9M |
| Short-term investments | $9.9M | $3.5M | $12.4M | $10.3M | $8.7M | $17.6M | $21.1M | $24.7M | $28.0M | — | — | — |
| Receivables | $17,000 | $52,000 | $23,000 | $72,000 | $42,000 | $27,000 | $400,000 | $400,000 | $0 | $100,000 | $1.1M | $500,000 |
| Inventory | $0 | $0 | −$23,000 | −$72,000 | −$42,000 | −$27,000 | −$400,000 | −$400,000 | $0 | −$100,000 | −$200,000 | $1 |
| Other current assets | $850,000 | $1.4M | $1.5M | $956,000 | $1.9M | $1.7M | $2.6M | $1.2M | $2.6M | $3.2M | $3.3M | $653,999 |
| Total current assets | $26.2M | $19.8M | $19.3M | $26.0M | $20.9M | $28.0M | $35.5M | $42.3M | $48.3M | $52.9M | $58.9M | $12.0M |
| Property, plant & equipment (net) | $415,000 | $193,000 | $312,000 | $299,000 | $311,000 | $352,000 | $371,000 | $381,000 | $302,000 | $257,000 | $45,000 | $68,000 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $466,000 | $513,000 | $567,000 | $615,000 | $723,000 | $711,000 | $759,000 | $807,000 | $854,000 | $903,000 | $950,000 | $2.2M |
| Total assets | $27.1M | $20.5M | $20.2M | $26.9M | $21.9M | $29.1M | $36.7M | $43.5M | $49.5M | $54.1M | $59.9M | $14.3M |
| Liabilities | ||||||||||||
| Accounts payable | $1.7M | $2.3M | $1.1M | $1.5M | $3.8M | $1.5M | $1.2M | $1.2M | $294,000 | $516,000 | $321,000 | $1.9M |
| Short-term debt | $20.1M | $20.5M | $20.5M | $20.4M | $20.3M | $20.2M | $20.1M | $20.1M | $46,000 | $44,000 | $28,000 | $55,000 |
| Deferred revenue | — | — | — | — | — | — | −$54,000 | — | — | — | $2.7M | $2.7M |
| Total current liabilities | $25.6M | $25.8M | $23.6M | $23.8M | $26.7M | $25.1M | $25.0M | $23.6M | $2.6M | $4.0M | $46.3M | $5.4M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $19.9M | $19.9M | $19.8M | $19.7M |
| Lease obligations | $232,000 | $60,000 | $77,000 | $94,000 | $109,000 | $120,000 | $131,000 | $142,000 | $155,000 | $170,000 | $28,000 | $55,000 |
| Other long-term liabilities | $735,000 | $543,000 | $539,000 | $555,000 | $89,000 | $106,000 | $123,000 | $263,000 | $1.7M | $12.9M | $1.5M | $133.2M |
| Total liabilities | $26.3M | $26.3M | $24.1M | $24.3M | $26.7M | $25.2M | $25.1M | $23.8M | $24.3M | $36.8M | $67.6M | $158.3M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | — | — | $6,000 | $6,000 | $4,000 | $4,000 | $4,000 | $4,000 | $4,000 | $4,000 | $4,000 | $2,000 |
| Retained earnings (deficit) | −$188.2M | −$179.4M | −$170.2M | −$161.9M | −$153.6M | −$143.6M | −$134.3M | −$124.7M | −$117.8M | −$120.9M | −$139.9M | −$148.8M |
| Accumulated other comprehensive income | — | $0 | −$1,000 | $1,000 | $1,000 | −$18,000 | −$69,000 | −$82,000 | −$50,000 | $0 | −$59.9M | −$133.2M |
| Total shareholders' equity | $827,000 | −$5.8M | −$4.0M | $2.6M | −$4.8M | $3.9M | $11.6M | $19.6M | $25.2M | $17.3M | −$7.7M | −$144.0M |
| Key figures | ||||||||||||
| Total debt | $20.2M | $20.5M | $20.5M | $20.4M | $20.3M | $20.3M | $20.2M | $20.2M | $20.1M | $20.0M | $19.8M | $19.7M |
| Net cash (debt) | $5.1M | −$2.2M | −$2.7M | $4.6M | −$1.3M | $6.0M | $12.7M | $20.9M | $25.6M | $29.7M | $35.0M | −$8.8M |
| Working capital | $681,000 | −$6.0M | −$4.3M | $2.2M | −$5.8M | $2.9M | $10.6M | $18.7M | $45.7M | $48.9M | $12.6M | $6.6M |
| Tangible book value | $827,000 | −$5.8M | −$4.0M | $2.6M | −$4.8M | $3.9M | $11.6M | $19.6M | $25.2M | $17.3M | −$7.7M | −$144.0M |
| Book value per share | $0.31 | −$2.17 | −$1.61 | $1.35 | −$2.86 | $2.34 | $7.02 | $11.93 | $14.54 | $10.70 | −$4.75 | — |
| Shares outstanding | 2.7M | 2.7M | 2.5M | 1.9M | 1.7M | 1.7M | 1.6M | 1.6M | 1.7M | 1.6M | 1.6M | — |
| Current ratio | 1.03 | 0.77 | 0.82 | 1.09 | 0.78 | 1.12 | 1.42 | 1.79 | 18.38 | 13.30 | 1.27 | 2.23 |
| Quick ratio | 0.99 | 0.71 | 0.75 | 1.06 | 0.71 | 1.05 | 1.34 | 1.76 | 17.38 | 12.52 | 1.21 | 2.11 |
| Debt / equity | 24.48 | — | — | 7.93 | — | 5.21 | 1.75 | 1.03 | 0.80 | 1.16 | — | — |
| Equity / assets | 3.0% | −28.2% | −19.7% | 9.6% | −21.9% | 13.4% | 31.5% | 45.1% | 51.0% | 32.0% | −12.8% | −1,008.4% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 26, 2024); data from EODHD.
EFTR financial position
At the end of fiscal 2023 (December 31, 2023), eFFECTOR Therapeutics had total assets of $20.5 million (down 29.3% from a year earlier), total liabilities of $26.3 million and shareholders' equity of -$5.8 million. It held $18.4 million in cash and short-term investments against $20.5 million of debt, net debt of $2.2 million. Its current ratio was 0.77. In the latest quarter (ended March 31, 2024) total assets were $27.1 million and equity $0.8 million.
Related: EFTR income statement, EFTR cash flow statement, EFTR key metrics. See the EFTR stock overview for the latest quote and news.
EFTR balance sheet FAQ
What are eFFECTOR Therapeutics's total assets?
eFFECTOR Therapeutics reported total assets of $20.5 million at the end of fiscal 2023 (December 31, 2023), compared with $29.1 million a year earlier.
How much debt does eFFECTOR Therapeutics have?
eFFECTOR Therapeutics had $20.5 million of total debt at the end of fiscal 2023, including short-term borrowings and lease obligations. Its debt-to-equity ratio was —.
How much cash does eFFECTOR Therapeutics have?
eFFECTOR Therapeutics held $18.4 million in cash and short-term investments at the end of fiscal 2023; with $20.5 million of debt that is net debt of $2.2 million.
What is eFFECTOR Therapeutics's book value?
eFFECTOR Therapeutics's shareholders' equity (book value) was -$5.8 million at the end of fiscal 2023, or −$2.65 per share.
What is eFFECTOR Therapeutics's current ratio?
eFFECTOR Therapeutics had current assets of $19.8 million and current liabilities of $25.8 million, a current ratio of 0.77 (current liabilities exceed current assets).